Formulation & Development

At Cura Healthcare, innovation is at the heart of our formulation development strategy. Our Formulation Development & Research Division is committed to creating high-quality, patient-centric, and commercially viable pharmaceutical, nutraceutical, veterinary, cosmetic, and herbal products that meet the evolving needs of global healthcare markets. Working in close collaboration with our network of WHO-GMP and internationally accredited manufacturing facilities, our experienced team of formulation scientists, pharmacists, and regulatory professionals develops innovative formulations across a broad range of dosage forms, including tablets, capsules, injections, oral liquids, dry syrups, topical preparations, powders, sachets, effervescent tablets, softgel capsules, ophthalmics, and specialty drug delivery systems.

At Cura Healthcare, innovation is at the heart of our formulation development strategy. Our Formulation Development & Research Division is committed to creating high-quality, patient-centric, and commercially viable pharmaceutical, nutraceutical, veterinary, cosmetic, and herbal products that meet the evolving needs of global healthcare markets. Working in close collaboration with our network of WHO-GMP and internationally accredited manufacturing facilities, our experienced team of formulation scientists, pharmacists, and regulatory professionals develops innovative formulations across a broad range of dosage forms, including tablets, capsules, injections, oral liquids, dry syrups, topical preparations, powders, sachets, effervescent tablets, softgel capsules, ophthalmics, and specialty drug delivery systems.

At Cura Healthcare, innovation is at the heart of our formulation development strategy. Our Formulation Development & Research Division is committed to creating high-quality, patient-centric, and commercially viable pharmaceutical, nutraceutical, veterinary, cosmetic, and herbal products that meet the evolving needs of global healthcare markets. Working in close collaboration with our network of WHO-GMP and internationally accredited manufacturing facilities, our experienced team of formulation scientists, pharmacists, and regulatory professionals develops innovative formulations across a broad range of dosage forms, including tablets, capsules, injections, oral liquids, dry syrups, topical preparations, powders, sachets, effervescent tablets, softgel capsules, ophthalmics, and specialty drug delivery systems.

Our formulation development capabilities include:

  • New product formulation and development

  • Reverse engineering and generic product development

  • Value-added and differentiated formulations

  • Fixed-dose combination (FDC) development

  • Specialty and modified-release formulations

  • Technology transfer and scale-up

  • Analytical method development and validation

  • Stability study design and execution

  • Packaging compatibility studies

  • Regulatory documentation and dossier preparation

Every product is developed with a focus on quality, efficacy, safety, patient compliance, and regulatory compliance, following internationally accepted scientific and quality standards. Our integrated development approach enables faster commercialization while ensuring seamless technology transfer from laboratory to commercial manufacturing.

Driven by a culture of continuous innovation and scientific excellence, Cura Healthcare's Formulation Development & Research Division works closely with customers to transform ideas into market-ready healthcare solutions. From concept development to commercial production, we deliver customized formulations that help our partners succeed in both emerging and regulated pharmaceutical markets.

Our formulation development capabilities include:

  • New product formulation and development

  • Reverse engineering and generic product development

  • Value-added and differentiated formulations

  • Fixed-dose combination (FDC) development

  • Specialty and modified-release formulations

  • Technology transfer and scale-up

  • Analytical method development and validation

  • Stability study design and execution

  • Packaging compatibility studies

  • Regulatory documentation and dossier preparation

Every product is developed with a focus on quality, efficacy, safety, patient compliance, and regulatory compliance, following internationally accepted scientific and quality standards. Our integrated development approach enables faster commercialization while ensuring seamless technology transfer from laboratory to commercial manufacturing.

Driven by a culture of continuous innovation and scientific excellence, Cura Healthcare's Formulation Development & Research Division works closely with customers to transform ideas into market-ready healthcare solutions. From concept development to commercial production, we deliver customized formulations that help our partners succeed in both emerging and regulated pharmaceutical markets.

At Cura Healthcare, innovation is at the heart of our formulation development strategy. Our Formulation Development & Research Division is committed to creating high-quality, patient-centric, and commercially viable pharmaceutical, nutraceutical, veterinary, cosmetic, and herbal products that meet the evolving needs of global healthcare markets. Working in close collaboration with our network of WHO-GMP and internationally accredited manufacturing facilities, our experienced team of formulation scientists, pharmacists, and regulatory professionals develops innovative formulations across a broad range of dosage forms, including tablets, capsules, injections, oral liquids, dry syrups, topical preparations, powders, sachets, effervescent tablets, softgel capsules, ophthalmics, and specialty drug delivery systems.

Integrity

Doing the Right Thing, Always: At Cura Group, integrity is the foundation of every relationship and decision, guided by honesty, transparency, accountability, fairness, and ethical conduct. We honor our commitments, take responsibility for our actions, and consistently do what is right, building lasting trust, credibility, and responsible partnerships with customers, employees, suppliers, partners, and regulatory authorities.

Passion for Excelence

Excellence in Everything We Do: At Cura Group, excellence is a mindset reflected in our commitment to quality, precision, innovation, regulatory compliance, customer satisfaction, and continuous improvement. By fostering a culture of high standards, learning, accountability, and attention to detail, we consistently strive to exceed expectations and deliver reliable healthcare solutions that create lasting value and support our journey toward global healthcare leadership.

Transparency

Building Trust Through Openness: At Cura Group, transparency means conducting business with openness, honesty, clarity, integrity, and accountability. Through accurate and timely communication and open dialogue with employees, customers, partners, suppliers, and regulatory authorities, we build trust, strengthen collaboration, enable informed decisions, and foster lasting partnerships.

Concern for Society &

environment

Creating a Healthier and Sustainable Future: At Cura Group, we are committed to improving healthcare access, community well-being, environmental responsibility, and sustainable development. Through responsible use of resources, ethical practices, environmental and safety compliance, and meaningful community engagement, we strive to create lasting value for society while contributing to healthier communities and a cleaner, more sustainable future.

Fairness with Care

Respecting People, Valuing Every Individual: At Cura Group, we foster a culture of fairness, respect, equality, empathy, and inclusion, where every individual is valued, supported, and empowered to grow. By promoting equal opportunities, recognizing diverse perspectives, and treating employees, customers, partners, suppliers, and communities with dignity and care, we build trusted relationships and create lasting value for all.

Participative Decision Making

Collaboration that Drives Success: At Cura Group, we encourage collaboration, open communication, mutual respect, and shared responsibility, empowering our people to contribute ideas and expertise to informed decision-making. By embracing diverse perspectives, we strengthen innovation, accountability, teamwork, and ownership, enabling better decisions that support customer satisfaction, sustainable growth, and long-term success.

Oral Solid Dosage Forms

• Immediate Release (IR) Tablets • Film-Coated Tablets • Uncoated Tablets • Mouth Dissolving Tablets (MDTs) • Orally Disintegrating Tablets (ODTs) • Dispersible Tablets • Chewable Tablets • Effervescent Tablets • Sachets & Oral Powders

Modified Release Technologies

• Sustained Release (SR) Tablets • Extended Release (ER) Tablets • Delayed Release (DR) Tablets • Controlled Release (CR) Tablets • Gastro-Retentive Drug Delivery Systems

Specialty Oral Formulations

• Bilayer Tablets • Oral Oncology Tablets & Capsules • Fixed Dose Combination (FDC) Formulations • High Potency Formulations

Capsule Formulations

• Hard Gelatin Capsules • Soft Gelatin Capsules • Powder-Filled Capsules • Pellet-Filled Capsules • Tablet-in-Capsule Systems • Modified Release Capsules

Liquid Oral Preparations

• Oral Solutions • Oral Suspensions • Oil-Based Suspensions • Dry Syrups for Oral Suspension • Syrups & Pediatric Formulations

Topical & Dermatological Products

• Creams • Ointments • Gels • Lotions • Foams • Topical Solutions • Medicated Personal Care Products

Sterile & Parenteral Products

• Liquid Injections • Dry Powder Injections • Lyophilized (Freeze-Dried) Injections • Pre-filled Syringes • Sterile Infusions

Ophthalmic, ENT & Specialty Drug Delivery

• Ophthalmic Preparations • Nasal Drug Delivery Systems • Innovative Sterile Drug Delivery Platforms

Advanced Dosage Forms & Drug Delivery Technologies

At Cura Group, we specialize in the development and manufacturing of a comprehensive range of conventional, specialty, and innovative dosage forms designed to enhance patient compliance, therapeutic effectiveness, product stability, and market differentiation. Supported by our network of WHO-GMP, EU-GMP, and internationally accredited manufacturing facilities, we offer end-to-end formulation solutions for domestic and international markets.

Advanced Dosage Forms & Drug Delivery Technologies

At Cura Group, we specialize in the development and manufacturing of a comprehensive range of conventional, specialty, and innovative dosage forms designed to enhance patient compliance, therapeutic effectiveness, product stability, and market differentiation. Supported by our network of WHO-GMP, EU-GMP, and internationally accredited manufacturing facilities, we offer end-to-end formulation solutions for domestic and international markets.

Proprietary & Advanced Drug Delivery Technologies

Cura Group continuously invests in advanced formulation science to develop differentiated products with enhanced therapeutic performance and improved patient convenience. Our expertise includes:

  • Dual Retard Drug Delivery Technology

  • Bilayer & Tablet-in-Tablet Technology

  • Gastro-Retentive Drug Delivery Systems

  • Osmotic Controlled Release Technology

  • Compact Tablet Technology

  • Matrix-Based Sustained & Modified Release Systems

  • Long-Acting Injectable (LAI) Technologies

  • Nasal Drug Delivery Systems

  • Topical Foam Technology

  • Customized Drug Delivery Platforms

  • Technology Transfer & Scale-up Solutions

With strong formulation expertise, regulatory excellence, and innovative development capabilities, Cura Group provides customized dosage forms and advanced drug delivery solutions that help customers accelerate product launches and successfully compete in both emerging and regulated pharmaceutical markets.

Proprietary & Advanced Drug Delivery Technologies

Cura Group continuously invests in advanced formulation science to develop differentiated products with enhanced therapeutic performance and improved patient convenience. Our expertise includes:

  • Dual Retard Drug Delivery Technology

  • Bilayer & Tablet-in-Tablet Technology

  • Gastro-Retentive Drug Delivery Systems

  • Osmotic Controlled Release Technology

  • Compact Tablet Technology

  • Matrix-Based Sustained & Modified Release Systems

  • Long-Acting Injectable (LAI) Technologies

  • Nasal Drug Delivery Systems

  • Topical Foam Technology

  • Customized Drug Delivery Platforms

  • Technology Transfer & Scale-up Solutions

With strong formulation expertise, regulatory excellence, and innovative development capabilities, Cura Group provides customized dosage forms and advanced drug delivery solutions that help customers accelerate product launches and successfully compete in both emerging and regulated pharmaceutical markets.